Correction to: Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder

Andrew W Zimmerman¹, Kanwaljit Singh², Susan L Connors², Hua Liu³, Anita A Panjwani^{4

5}, Li-Ching Lee⁶, Eileen Diggins², Ann Foley², Stepan Melnyk⁷, Indrapal N Singh⁸, S Jill James⁷, Richard E Frye⁸, Jed W Fahey^{3

4

9}

Affiliations

¹ Departments of Pediatrics, Neurology and Psychiatry, University of Massachusetts Medical School, 55 N. Lake Ave., Worcester, MA, 01655, USA. Andrew.Zimmerman@umassmemorial.org.
² Departments of Pediatrics, Neurology and Psychiatry, University of Massachusetts Medical School, 55 N. Lake Ave., Worcester, MA, 01655, USA.
³ Department of Pharmacology and Molecular Sciences, and The Cullman Chemoprotection Center, Johns Hopkins University School of Medicine, 725 N. Wolfe St., Baltimore, MD, 21205, USA.
⁴ Department of Psychiatry and Behavioral Sciences, and iMIND Hopkins, Johns Hopkins University School of Medicine, 600 N. Wolfe St., Baltimore, MD, 21287, USA.
⁵ Department of Psychological Sciences, Purdue University, 703 3rd St., West Lafayette, IN, 47907, USA.
⁶ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., Baltimore, MD, 21205, USA.
⁷ Department of Pediatrics, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR, 72205, USA.
⁸ Barrow Neurologic Institute at Phoenix Children's Hospital and Department of Child Health, University of Arizona College of Medicine - Phoenix, 475 N. 5th St., Phoenix, AZ, 85004, USA.
⁹ Department of Medicine, Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, 600 N. Wolfe St., Baltimore, MD, 21287, USA.

Published Erratum

Andrew W Zimmerman et al. Mol Autism. 2021.

. 2021 Jun 16;12(1):44.

doi: 10.1186/s13229-021-00451-9.

¹ Departments of Pediatrics, Neurology and Psychiatry, University of Massachusetts Medical School, 55 N. Lake Ave., Worcester, MA, 01655, USA. Andrew.Zimmerman@umassmemorial.org.
² Departments of Pediatrics, Neurology and Psychiatry, University of Massachusetts Medical School, 55 N. Lake Ave., Worcester, MA, 01655, USA.
³ Department of Pharmacology and Molecular Sciences, and The Cullman Chemoprotection Center, Johns Hopkins University School of Medicine, 725 N. Wolfe St., Baltimore, MD, 21205, USA.
⁴ Department of Psychiatry and Behavioral Sciences, and iMIND Hopkins, Johns Hopkins University School of Medicine, 600 N. Wolfe St., Baltimore, MD, 21287, USA.
⁵ Department of Psychological Sciences, Purdue University, 703 3rd St., West Lafayette, IN, 47907, USA.
⁶ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., Baltimore, MD, 21205, USA.
⁷ Department of Pediatrics, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR, 72205, USA.
⁸ Barrow Neurologic Institute at Phoenix Children's Hospital and Department of Child Health, University of Arizona College of Medicine - Phoenix, 475 N. 5th St., Phoenix, AZ, 85004, USA.
⁹ Department of Medicine, Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, 600 N. Wolfe St., Baltimore, MD, 21287, USA.

No abstract available

Erratum for

Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder.
Zimmerman AW, Singh K, Connors SL, Liu H, Panjwani AA, Lee LC, Diggins E, Foley A, Melnyk S, Singh IN, James SJ, Frye RE, Fahey JW. Zimmerman AW, et al. Mol Autism. 2021 May 25;12(1):38. doi: 10.1186/s13229-021-00447-5. Mol Autism. 2021. PMID: 34034808 Free PMC article. Clinical Trial.

1. Zimmerman AW, et al. Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder. Mol Autism. 2021;12:38. doi: 10.1186/s13229-021-00447-5. - DOI - PMC - PubMed